Condition: Hypertension,Essential · Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences
The purpose of this study is: 1. To evaluate the efficacy of Songling Xuemaikang Capsules(SLXMKC) with grade 1 hypertension. 2. To reveal the potiential effects of SLXMKC on vascular function and structure of patients with grade 1 hypertension. 3. To explore the underlying mechanisms of the therapeutic effects of SLXMKC on the intervention of grade 1 hypertension.
This description comes directly from the study's public registry record.
Anlu Wang, Doctor · 010-62835342 · wwanganlu@126.com
Qiyu Liu, Doctor · 010-18810722937 · liuqy9307@163.com
Always discuss trial participation with your own doctor first.
| Xiyuan Hospital of China Academy of Chinese Medical Sciences | Beijing, Beijing Municipality, China | Recruiting |
| Suzhou Hosptial of Traditional Chinese Medicine | Suzhou, Jiangsu, China | Not Yet Recruiting |
| Affiliated Hospital of Shandong University of Traditional Chinese Medicine | Jinan, Shandong, China | Not Yet Recruiting |
| China Academy of Chinese Medical Sciences Xiyuan Hospital Jining Hospital | Jining, Shandong, China | Not Yet Recruiting |
| China Academy of Chinese Medical Sciences Xiyuan Hospital Shanxi Hospital | Taiyuan, Shanxi, China | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06093932